UnitedHealth Sells Stake in Florida Health Business to Private Equity Firm TPG
New York, Wednesday, 9 September 2026.
UnitedHealth Group has partnered with private equity firm TPG, selling a stake in its Florida Optum Health operations to streamline focus and boost thin margins following recent profit declines.
Market Reaction to Strategic Divestment
UnitedHealth Group Inc. (NYSE: UNH) shares experienced significant volatility on Wednesday, September 9, 2026, following reports that the healthcare giant has divested a stake in a portion of its Optum Health operations in Florida [1]. Market data indicated selling pressure early in the session, with some reports showing the stock opened down by 3.79% before fluctuating throughout the day [2]. While some market trackers noted a decline of 2.49% to $390.90, other data sources suggested shares edged up 0.54% to $401.89 by the end of the trading period, reflecting mixed investor sentiment regarding the transaction [1][3]. The buyer identified in reports is the private equity firm TPG Inc., a partnership aimed at refining the company’s operational focus [1]. This transaction occurs as institutional investors evaluate the potential implications for Optum’s regional growth strategy and overall margin profile in the health services sector [1].
Financial Performance and Margin Pressures
The decision to partner with TPG comes amidst a challenging financial backdrop for UnitedHealth Group, which reported a substantial drop in profit during the previous fiscal year [1]. In fiscal 2025, the group saw revenue rise 12% to $447.6 billion, yet operating profit fell 41% to $19 billion [1]. Adjusted diluted earnings per share also contracted significantly, falling from $27.66 to $16.35 over the same period [1]. Current operating margins for Optum Health are estimated at approximately 2%, a figure that management aims to improve through this strategic restructuring [2][4]. Market concerns contributing to the stock pullback include persistent medical utilization trends and extended timelines for commercial margin normalization in Medicare Advantage and Optum Health [2].
Strategic Outlook and Future Targets
UnitedHealth Group’s Chief Financial Officer Wayne DeVeydt emphasized that the transaction was not driven by a need for capital but rather by a desire for focus and local-level partnership [1]. Management expects Optum Health’s operating margins to improve from approximately 2% in 2026 to 4% in 2027 and 6% in 2028, representing a 2 percentage point increase over the next year [4]. Analyst consensus remains mixed, with an average price target of $473.18, though 21 major funds have recently reduced equity stakes in the company [2]. While the company maintains a strong market capitalization ranging between $359.79 billion and $447.93 billion depending on the valuation metric used, the focus remains on executing this turnaround strategy effectively [2][4].